Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00721435 · ClinicalTrials.gov registry record · NA

Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions

A NA study of Breast Cancer and Mass Cystic, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
183
Enrollment target
2
Study locations

NCT00721435: Completed NA study of Breast Cancer and Mass Cystic, sponsored by University of Michigan.

NCT00721435 is a NA study of Breast Cancer and Mass Cystic that has completed, run by University of Michigan. The registered enrollment target is 183 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00721435, a NA study of Breast Cancer and Mass Cystic, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
183 participants
Enrollment target
2
Study locations

Study Summary

The study will evaluate and refine a breast screening and diagnosis device.

Interventions

  • PROCEDURE 3D Tomosynthesis and ultrasound imaging

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor
  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2002-04
Est. Completion 2016-10
Phase NA
University of Michigan

1,327 total trials

What the finished NCT00721435 record still lists

NCT00721435 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which 3D Tomosynthesis and ultrasound imaging is the first listed.

NCT00721435 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT00721435 about?

NCT00721435 is a clinical study titled "Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions". The study will evaluate and refine a breast screening and diagnosis device.

What is the current status of trial NCT00721435?

This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2002-04. Estimated completion is 2016-10.

What conditions does trial NCT00721435 study?

This clinical trial studies the following conditions: Breast Cancer, Mass Cystic, Benign Mass.

What interventions are being tested in trial NCT00721435?

The interventions under investigation include: 3D Tomosynthesis and ultrasound imaging (PROCEDURE).

Who is sponsoring clinical trial NCT00721435?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00721435 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00721435's enrollment target sits among peer trials

183 402nd of 1224 higher than 821 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03859297 · 183 participants · NA

    Mechanisms of Rumination Change in Adolescent Depression

  • NCT04270591 · 183 participants · Phase 1

    Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

  • NCT06764615 · 183 participants · Phase 2

    A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • NCT06872684 · 183 participants · NA

    Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00721435, the US trial registry maintained by the National Library of Medicine. NCT00721435 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.